Dream Recall Frequency among Patients in a Psychiatric Outpatient Clinic in Ile-Ife, Nigeria by Mume, CO
DOI: 10.4176/090408    Original Article 
  
  
 
Dream Recall Frequency among Patients in a Psychiatric  
Outpatient Clinic in Ile-Ife, Nigeria 
 
Mume CO 
 
Department of Mental Health, Obafemi Awolowo University, Ile–Ife, Osun State, Nigeria 
 
Abstract 
Aim: The aim of this study was to find out if the frequency of dream recall among neuropsychiatric patients on 
psychotropic drugs was significantly different from that of healthy individuals. Methods: The study was done on 53 
neuropsychiatric patients with different diagnoses who were on medication and 144 healthy individuals. The number of 
participants in each group who recalled their dreams and those who did not were compared and analyzed statistically for any 
significant difference. Results: Thirty-five out of the 53 neuropsychiatric patients and 133 out of the 144 healthy individuals 
were able to recall their dreams. A significantly (p < 0.001) higher proportion of the healthy individuals compared to 
neuropsychiatric patients on medications were able to recall their dreams. Conclusions:  This study has shown that 
neuropsychiatric patients on medications may have reduced dream episodes or that their ability to remember their dreams 
may be impaired. A combination of both factors is not unlikely. Thus, the patients have reduced dream recall frequency 
(DRF) compared to healthy subjects. There might also be individuals who do not dream. 
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Introduction 
A dream is a mental activity that occurs during sleep. 
Dreams involve a visual experience with a plot that 
evolves over time. They are more or less considered to 
occur every night in every person. This presumption is 
based on the high recall rates following awakenings from 
rapid eye movement (REM) sleep and sometimes also 
following non-rapid eye movement (NREM) sleep [¬¬1].   
 
Dreams differ from person to person, and even for the 
same individual. Also dreams differ from night to night. 
Studies have shown that the dreams of various patients 
with one psychiatric disease are different from another 
group of patients with different psychiatric problem. For 
example, while schizophrenic patients dream 
predominantly about strangers, depressed patients tend to 
dream about family members [2]. Many psychotropic 
drugs, such as the benzodiazepines and the neuroleptics, 
tend to decrease dream recall frequency [3]. 
 
While there is generally no direct relationship between 
dream recall frequency and socioeconomic status [4], 
dream recall frequency has been found to vary with age 
and gender. The ability to recall dreams declines with age, 
and females are said to have higher dream recall 
frequency than males [5].  
 
Studies on dreams have been done in Nigeria [6,7] but 
none of these studies compared dream recall of 
neuropsychiatric patients who were on medication with 
dream recall in healthy individuals. This study was 
designed to accomplish this objective. 
 
Materials and methods 
The Ethics and Research Committee of the Obafemi 
Awolowo University Teaching Hospitals Complex, Ile-Ife, 
Nigeria, approved this study. The participants were 
informed that the information they would give would be 
used for research purposes and that their anonymity 
would be maintained. 
 
This study took place in Ile-Ife, a university town in 
Osun State, in southwestern Nigeria. The first group of 
subjects consisted of fifty-three patients attending the 
Psychiatric Outpatient Clinic of the Obafemi Awolowo 
University Teaching Hospitals Complex, Ile-Ife. Forty 
patients had a schizophrenic disorder, two had bipolar 
affective disorder, five had depressive episodes, and six 
had a seizure disorder. All these patients had recovered 
from the acute phase of their illnesses and were 
asymptomatic, but were on maintenance psychotropic 
drugs. They attended the clinic regularly and 
demonstrated evidence of good drug compliance. They 
were all literate in English language. The patients were 
seen during their routine attendance at the clinic.   
 
The second group of participants consisted of 144 
healthy individuals who were not on medications. They 
reside and work in or around Ile-Ife and were all literate in 
English language. They were recruited using a random 
sampling method, and were age- and sex- matched with 
the patients.  
 
All the subjects were asked to give the number of 
dreams they had in the preceding one month and if 
necessary to calculate it based on the number of dreams 
they had in the preceding one week. Information was 
obtained by using a questionnaire for both groups, but for 
the patients additional information such as the diagnosis 
and medication was obtained from their case notes. 
 
Results 
The age range for the psychiatric patients was 18 – 52 
years, with a mean of 34.2 years (SD = 8.8). The range 
for the healthy control individuals was 17 – 50 years, with 
a mean of 33.5 years (SD = 10.2). Among the 53 patients, 
there were 29 males (54.7%) and 24 females (45.3%). 
Out of the 144 controls, there were 79 males (54.9%) and 
65 females (45.1%). The socio–demographic 
characteristics of the participants are shown in Table 1. In 
each group, some participants indicated they do not 
dream. All those who reported that they could recall at 
least one dream per month were put together as dream 
recallers while those who indicated that they do not dream 
were designated as non-recallers.   
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Thirty-five out of the 53 neuropsychiatric patients (66%) 
and 133 out of the 144 healthy individuals (92.4%) were 
able to recall their dreams; the difference between these 
frequencies was statistically significant (p < 0.001) (Table 
2). 
 
Table 1  Socio-demographic characteristic of the subjects in the 
different groups 
  Healthy 
individuals 
Psychiatric  
patients 
Age range 
(years) 
17-50 18-52 
Male 
Female 
79 
65 
29 
24 
Single 
Married 
Separated 
Divorced 
Widowed 
50 
88 
3 
1 
2 
29 
18 
3 
2 
1 
 
Table 2 Dream Recall (at least once per month) - Healthy 
individuals versus Psychiatric Patients on Neuroleptics/ 
Antidepressants 
Dream recall  Status 
  yes no 
Total 
Healthy individuals  133  144  11 
Psychiatric patients  35  8  53  1
2 χ  = 19.338, df = 1, p < 0.001 
 
The comparison of dream recall ability between 
schizophrenic patients receiving neuroleptics (n=40) and 
the control group (n=144) showed that 133 out of 144 
(92.4%) normal subjects and 28 out of 40 schizophrenics 
(70%) recalled their dreams, and the difference was 
significant (X2 =  12.34, P < 0.05). On the other hand, 28 
out of 40 schizophrenic patients (70%) and 7 out of 13 
non-schizophrenic patients (53.8%) recalled their dreams, 
but the difference was not statistically significant (X2 = 
0.535, P = 0.465). 
 
A separate comparison of dream recall ability between 
all the patients (N53) and the control subjects (N144) was 
also done using the mean number of dreams over the 
previous month for the two groups. For the control group, 
the mean number of dreams ± standard error of the mean 
was 23.4±1.2, while in the patients it was 12.2 ±0.4  (t = 
5.612, df = 195, p = 0.000). This shows that dream recall 
was significantly better among the healthy participants.   
 
Table 3 shows the sex distribution of the patients as 
well as the number of males and females who could recall 
their dreams. There was no statistically significant 
difference in dream recall between the male and female 
patients (p =0.839).  
 
The different psychotropic drugs the patients were on 
and their dream recall frequencies are shown in Table 4. 
All the patients suffering from seizure disorder were on 
carbamazepine whereas all those with a diagnosis of 
depressive episode were on amitriptyline. The 
schizophrenic patients were on various neuroleptics. This 
was also the case for bipolar patients.  
Discussion 
There are a number of issues in the consideration of the 
observed difference in dream recall frequency between 
the subjects in the Psychiatric Outpatient Clinic and the 
healthy individuals. The patients in the clinic were 
primarily in remission from diseases that affect the central 
nervous system (CNS). They were also on centrally acting 
drugs. These conditions and drugs used to treat them 
affect not only sleep, but also cognition, which may 
include dream recall. It is also possible that some 
individuals do not dream.  
in depression are considered to be a 
re
 
Previous studies suggest that dreams are affected by 
drugs acting on the central cholinergic system. For 
example, scopolamine has been shown to prevent dreams 
or dream recall in healthy adults [8]. 
 
The emerging concepts of sleep neurophysiology are 
consistent with the cholinergic-aminergic imbalance 
hypothesis of mood (affective) disorders, which associates 
depression with an increased ratio of central cholinergic to 
aminergic neurotransmission. The characteristic sleep 
abnormalities seen 
flection of relative predominance of cholinergic activity 
[9].  
 
Table 3 Sex distribution and dream recall among the psychiatric 
patients 
Dream recall  Sex 
  yes no 
Total 
Males 20  9  29 
Females 15  9  24 
2
= 0.041, df = 1, p = 0.839 
 
Table 4 The different psychotropic drugs used by the patients 
and the respective dream recall distribution 
χ
Dream recall   
Drugs  yes no 
Total 
Fluphenerzine 
decanoate/ 
Chlorpromazine 
9 3 
12 
Fluphenerzine 
decanoate 
2 0 
2 
Chlorpromazine 3  6  9 
Trifuoperazine 5  2  7 
Haloperidol 7  0  7 
Carbamazepine 5  1  6 
Amitriptyline 2  2  4 
Amitriptyline/ 
Chlorpromazine 
0 2 
2 
Risperidone 2  2  4 
 
Antidepressant drugs reduce rapid eye movement (REM) 
sleep presumably by their anticholinergic properties [9]. 
Selective serotonin reuptake inhibitors (SSRI) have also 
be
linergic 
pr
en reported to cause a decrease in dream frequency, 
which may be a reflection of serotonergic REM 
suppression [10]. 
 
any antipsychotic drugs have intrinsic anticho M
operties. In addition antipsychotics result in different 
changes in sleep. In one study [11], significant increase in 
total sleep time (both REM and NREM sleep) with 
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decreases in wake time were observed after treatment 
with olanzapine, while decreases in wake time and REM 
sleep were observed with risperidone. In the same study, 
the use of haloperidol was associated with increases in 
NREM sleep and a tendency to decrease wake time.  
 
Increased frequency of nocturnal awakening is known to 
recall frequency of psychiatric inpatients in comparison 
with healthy controls [13],  that p ’ 
dream recall frequency was related to low sleep quality 
and frequent nocturnal aw ings and not  er 
substantially from that of he y controls t is wor of 
note that the psychiatric patients in this study were all 
f the study. 
Thus, drugs that increase total sleep time, reduce REM 
sleep and/   decrease wa ociated with a 
low frequ dream recall.
patients i udy had a  icant er dream recall 
than healthy individuals. Again, although the patients did 
n obvious clinic evide  of cognitive 
impairment, there still exists a likelihood that their primary 
p ributed to  eir p  dream
f
an issue to e add ed: among the 
healthy individuals, there were some who reported that 
t , as has been reported by others [7].  
Pagel [14] evaluated a group of subjects who reported 
never having recalled a dream and reported no  ams 
when awakened during p somnographically defined 
s ncluded that such individuals might not 
experience dreaming. Similarly, it is possible that some of 
th
1. Nielsen TA. A review of mentation in REM and NREM sleep: 
erman 
 EF, Gersh T, Silvestri R, Stickgold R, Salzman C, 
obson JA. SSRI treatment suppresses dream recall frequency 
 M. and Engelhardt, H. Dreaming and 
sychopathology: dream recall and dream content of  increase dream recall frequency [12]. In a study of dream 
it was found  atients
aken  did  diff
alth . I thy 
stable and had no sleep difficulty just before or at the time 
o
 
or ke time are ass
 That would explain why the  ency of 
n this st signif ly low
ot show  al  nce
athology cont
requency. 
th oor  recall 
 
There is still   b ress
hey do not dream
dre
oly
leep and co
e participants in the present study (both patients and 
healthy individuals) do not experience dreaming. More 
studies on dream recall, awakening subjects during 
polysomnographically defined sleep, will resolve this issue. 
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